SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891618-03-005918
Filing Date
2003-11-13
Accepted
2003-11-13 16:25:35
Documents
6
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f94338ore10vq.htm 10-Q 260152
3 EXHIBIT 10.17.2 f94338orexv10w17w2.txt EX-10.17.2 8546
4 EXHIBIT 10.41 f94338orexv10w41.txt EX-10.41 34569
5 EXHIBIT 31.1 f94338orexv31w1.htm EX-31.1 7082
6 EXHIBIT 31.2 f94338orexv31w2.htm EX-31.2 7071
7 EXHIBIT 32.1 f94338orexv32w1.htm EX-32.1 6241
  Complete submission text file 0000891618-03-005918.txt   325748
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22570 | Film No.: 03998462
SIC: 2833 Medicinal Chemicals & Botanical Products